- Home
- RNA vs PMI Comparison
RNA vs PMI Comparison
Compare RNA & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNA | PMI |
|---|---|---|
| Founded | 2012 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 227.6M | 202.7M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | RNA | PMI |
|---|---|---|
| Price | $13.72 | $1.01 |
| Analyst Decision | Buy | |
| Analyst Count | 20 | 0 |
| Target Price | ★ $69.26 | N/A |
| AVG Volume (30 Days) | ★ 381.5K | 142.0K |
| Earning Date | 01-01-0001 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $88.12 | N/A |
| Revenue Next Year | $18.11 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.95 | $0.92 |
| 52 Week High | $73.06 | $13.68 |
Technical Indicators
Market Signals| Indicator | RNA | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 15.22 | 42.63 |
| Support Level | $13.06 | $0.92 |
| Resistance Level | $72.89 | $1.37 |
| Average True Range (ATR) | 0.50 | 0.08 |
| MACD | 2.01 | 0.01 |
| Stochastic Oscillator | 74.12 | 36.69 |
Price Performance
Historical ComparisonAbout RNA Avidity Biosciences Inc.
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
About PMI Picard Medical Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.